Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells

被引:45
作者
Wang, Fei [1 ]
Liu, Shengnan [1 ]
Xi, Shuhua [1 ]
Yan, Ling [1 ]
Wang, Huihui [1 ]
Song, Yingli [1 ]
Sun, Guifan [1 ]
机构
[1] China Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Liaoning Prov Key Lab Arsen Biol Effect & Poisoni, Shenyang 110001, Peoples R China
基金
中国国家自然科学基金;
关键词
Arsenite; HIF-1; alpha; COX-2; VEGF; MAPK; PI3K/AKT; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACTIVATED PROTEIN-KINASE; DRINKING-WATER; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVITY; MONOMETHYLARSONOUS ACID; VEGF EXPRESSION; FACTOR-I; CYCLOOXYGENASE-2; CANCER;
D O I
10.1016/j.toxlet.2013.08.008
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Arsenic, a well-established human carcinogen, can cause various types of cancers, including bladder cancer. Angiogenesis is a key event for tumor initiation. In this study, several important angiogenesis related factors, including cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1 alpha (HIF-1 alpha), were up-regulated and PI3K/AKT and MAPK signal pathways were activated in human uroepithelial cell line (SV-HUC-1) treated with NaAsO2 (0, 1, 2, 4, 8 or 10 mu M) for 24 h. Arsenite-induced HIF-1 alpha, VEGF and COX-2 expressions were decreased by PI3K inhibitors. Blockage of the ERK1/2, p38 and JNK down-regulated the VEGF level, while ERK1/2 and p38 inhibitors were more effective than JNK in attenuating arsenite-induced COX-2 expression. HIF-1 alpha expression was only decreased by ERK1/2 inhibitor. It was found that superoxide (O-2(center dot-)) generation was involved in arsenite-induced the activation of MAPK and PI3K pathways, which led to the HIF-1 alpha, COX-2 and VEGF overexpressions. In conclusion, arsenite-induced COX-2, VEGF and HIF-1 alpha expressions, mediated partially by reactive oxygen species (ROS), were regulated by MAPK and PI3K/AKT signaling pathways in human uroepithelial cells. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 57 条
[31]   Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice [J].
Liu, CH ;
Chang, SH ;
Narko, K ;
Trifan, OC ;
Wu, MT ;
Smith, E ;
Haudenschild, C ;
Lane, TF ;
Hla, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18563-18569
[32]  
Liu L. Z., 2011, PLOS ONE
[33]   Effects of acetaminophen on reactive oxygen species and nitric oxide redox signaling in kidney of arsenic-exposed rats [J].
Majhi, Chhaya Rani ;
Khan, Saleem ;
Leo, Marie Dennis Marcus ;
Manimaran, Ayyasamy ;
Sankar, Palanisamy ;
Sarkar, Souvendra Nath .
FOOD AND CHEMICAL TOXICOLOGY, 2011, 49 (04) :974-982
[34]   Hypoxia inducible factor-1-independent pathways in tumor angiogenesis [J].
Mizukami, Yusuke ;
Kohgo, Yutaka ;
Chung, Daniel C. .
CLINICAL CANCER RESEARCH, 2007, 13 (19) :5670-5674
[35]   VEGF receptor signalling - in control of vascular function [J].
Olsson, AK ;
Dimberg, A ;
Kreuger, J ;
Claesson-Welsh, L .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (05) :359-371
[36]   Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism [J].
Pore, N ;
Liu, S ;
Shu, HK ;
Li, B ;
Haas-Kogan, D ;
Stokoe, D ;
Milanini-Mongiat, J ;
Pages, G ;
O'Rourke, DM ;
Bernhard, E ;
Maity, A .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (11) :4841-4853
[37]   Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder [J].
Ristimäki, A ;
Nieminen, O ;
Saukkonen, K ;
Hotakainen, K ;
Nordling, S ;
Haglund, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :849-853
[38]   Regulation of antioxidant enzymes:: a significant role for melatonin [J].
Rodriguez, C ;
Mayo, JC ;
Sainz, RM ;
Antolín, I ;
Herrera, F ;
Martín, V ;
Reiter, RJ .
JOURNAL OF PINEAL RESEARCH, 2004, 36 (01) :1-9
[39]   Cancer incidence and pattern of arsenic concentration in drinking water wells in Cordoba, Argentina [J].
Rosana Aballay, Laura ;
del Pilar Diaz, Maria ;
Matias Francisca, Franco ;
Edith Munoz, Sonia .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL HEALTH RESEARCH, 2012, 22 (03) :220-231
[40]   Targeting HIF-1 for cancer therapy [J].
Semenza, GL .
NATURE REVIEWS CANCER, 2003, 3 (10) :721-732